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Background: Malaria vector control relies principally on the use of insecticides, especially pyrethroids. Because
of the increasing occurrence of insecticide resistance in target vector populations, the development of new
insecticides, particularly those with novel modes of action, is particularly important, especially in terms of managing
insecticide resistance. The C8910 formulation is a patented mixture of compounds comprising straight-chain
octanoic, nonanoic and decanoic saturated fatty acids. This compound has demonstrated toxic and repellent effects
against several arthropod species. The aims of this study were to measure the insecticidal effects of C8910 against
an insecticide susceptible (FANG) and a pyrethroid resistant (FUMOZ-R) laboratory strain of An. funestus as well as
against wild-caught An. funestus material from Zambia (ZamF), and to investigate the repellent effects of two
formulations of C8910 against these strains.
Methods: Toxicity against adult females was assessed using a range of concentrations based on the CDC bottle
bioassay method and repellence of three different C8910 formulations was assessed using standard choice-chamber
bioassays.
Results: C8910 proved equally toxic to adult females of the FUMOZ-R and FANG laboratory strains, as well as to
adult females of the wild-caught (ZamF) sample. None of the C8910 formulations tested gave any conclusive
indication of repellence against any of the strains.
Conclusion: C8910 is equally effective as an adulticide against pyrethroid resistant and insecticide susceptible
An. funestus. However, the formulations tested did not show any consistent repellence against laboratory reared
and wild-caught female samples of this species. Nevertheless, C8910 shows potential as an adulticide that can be
used for malaria vector control, particularly in those instances where insecticide resistance management is required.
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The World Health Organization (WHO) estimates that
198 million cases of malaria and 584,000 resultant
deaths occurred globally in 2013 [1]. The vast majority
of malaria cases occur in the Afrotropical region.
Anopheles funestus Giles is a primary malaria vector
species in the Afrotropical region [2, 3] and is the nom-
inal member of the Funestus Subgroup which comprises
four species: An. funestus, An. parensis, An. vaneedeni
and An. confusus. These are almost morphologically in-
distinguishable at all life stages [3, 4]. Of these, only An.
funestus has been implicated in malaria transmission.
Anopheles funestus females are highly anthropophilic
and endophilic, and often take multiple blood meals.
These characteristics combined with a relatively high
longevity make An. funestus populations especially effi-
cient at malaria transmission, and often show higher
Plasmodium falciparum sporozoite infection rates than
other vector species [5].
A strong tendency toward endophily makes An. funes-
tus populations especially susceptible to control by in-
door spraying of residual insecticides (IRS). Currently,
only insecticides belonging to the pyrethroid, carbamate,
organophosphate and organochlorine (DDT only) classes
are available for malaria vector control. These collectively
target only two insect neurological sites (the sodium ion
channel and acetylcholinesterase) [6], which makes the de-
velopment of resistance and cross-resistance between clas-
ses a likely prospect in regions where insecticide selection
is suitably intense. The rate of resistance development is
also exacerbated by the use of these insecticides for agri-
cultural pest control [7]. Several populations of An. funes-
tus have developed resistance to insecticides including
pyrethroids (type I and II), carbamates (bendiocarb and
propoxur), the organochlorine DDT and the cyclodiene
dieldrin (reviewed by Coetzee & Koekemoer [8]).
The many instances of insecticide resistance in An.
funestus highlight a significant problem facing insecti-
cide based vector control strategies, the consequences
of which are exemplified by the malaria epidemic of
1996–2000 experienced in northern KwaZulu-Natal,
South Africa [9, 10]. During this epidemic, pyrethroid
and carbamate resistant An. funestus were able to expand
their ranges into areas that were under pyrethroid-based
IRS control [11]. The epidemic was subsequently halted
by a range of interventions including the re-introduction
of DDT into the IRS programme as a resistance manage-
ment option [10]. Insecticide resistance in malaria vector
populations has become so widespread that malaria vector
control is synonymous with resistance management, and
has led to the development of the Global Plan for Insecti-
cide Resistance Management (GPIRM) [12].
Since the introduction of pyrethroids in the 1990s, no
new classes of insecticide have been approved by theWHO for use in public health [13]. The development of
new insecticides, particularly those with novel modes of
action, is particularly important, especially in terms of
managing insecticide resistance [14].
In combination with insecticide applications, topical
and spatial insect repellents are potentially useful in mal-
aria vector control [15, 16]. Several candidate repellents
have recently been identified [16]. However, their use as
alternatives is not widespread, and a reduction in the
efficacy of repellents can occur over time [17].
Fatty acids found naturally on human skin have shown
repellent effects against Aedes aegypti mosquitoes in-
cluding those attempting to bite or oviposit [18–20].
The C8910 formulation is a patented mixture of com-
pounds comprising straight-chain octanoic, nonanoic
and decanoic saturated fatty acids (C8, C9 and C10)
[21]. This formulation has demonstrated repellent effects
against biting and non-biting flies as well as ticks [22].
In addition, an incapacitating and toxic effect against
several mosquito species, including the dengue vector
Ae. aegypti [20] and several malaria vector species
including An. gambiae, An. dirus, An. farauti, An. free-
borni, An. minimus and An. stephensi [23], has been
observed. The mode of action of C8910 has not been
fully elucidated but likely involves respiratory inhib-
ition [21].
The aims of this study were to measure the insecticidal
effects of C8910 against insecticide susceptible and pyr-
ethroid resistant laboratory strains of An. funestus as
well as against wild-caught An. funestus from Zambia,
and to investigate the repellent effects of two formula-
tions of C8910 against these strains.
Methods
Mosquito strains
All of the mosquito strains/samples used in this study
are housed in the Botha De Meillon Insectary (BMDI) at
the National Institute for Communicable Diseases (NICD)
in Johannesburg.
Ethical clearance for the use of mosquitoes for research
purposes has been obtained from the Human Research
Ethics Committee (medical) of the University of the
Witwatersrand, Johannesburg (ref: W-CJ-100510-1).
Laboratory-reared colonies
FANG: This An. funestus colony originated from south-
ern Angola and has been kept in colony since 2003. It is
fully susceptible to insecticides. Specifically, adult males
and females exposed to 0.75 % permethrin for 1 h con-
sistently show 100 % mortality 24 h post exposure.
FUMOZ-R: This An. funestus colony has been selected
for pyrethroid resistance from the base colony (FUMOZ)
which originated from southern Mozambique and has
been kept in colony since July 2001 [24].
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ZamF: Samples of indoor-resting An. funestus Clade I,
highly resistant to pyrethroids and carbamates yet sus-
ceptible to DDT and organophosphates, were collected
in the Nchelenge District of Zambia during the first
quarter of 2014 [25]. Females were transported live to
the BDMI where they were induced to lay eggs. Hatched
larvae were reared through to adulthood and samples of
F1 adult progeny (as representative of the wild popula-
tion) were used for the toxicity and repellence tests de-
tailed below.
Toxicity assays
The CDC bottle bioassay protocol of Brogdon & Chan
[26] was used to assess the insecticidal effects of C8910
on the An. funestus colonies/wild-caught samples. C8910
was supplied in liquid form by the Centers for Disease
Control and Prevention (CDC; Atlanta, Georgia) and di-
luted in acetone to obtain a series of dilutions at a concen-
tration range of 50-400 μg a.i./ml. 1 ml of each C8910
solution was used to treat each bottle and controls in-
cluded bottles treated with acetone only. Twenty to
twenty-five adult female mosquitoes (aged 1–5 days old)
were gently introduced into each bottle. Knockdown,
which was defined as a mosquito on its back and unable
to right itself, was recorded at 15 min intervals over a 2 h
exposure period. The entire concentration range plus a
control was assessed through 3 replicates per colony/wild-
caught sample. Following exposure, mosquitoes were re-
moved from the bottles and placed into holding cups with
access to 10 % sucrose solution. Environmental controls
were conducted concurrently with unexposed mosquitoes
directly inserted into a holding cup with access to sucrose
solution. Final mortalities were recorded at 24 h post-
exposure.
All statistical analyses were done using IBM SPSS
(Armonk, NY). The mean Lethal Concentrations indu-
cing 50 % mortality (LC50s) were determined for each
colony/wild-caught sample using regression lines of
log-transformed mortality data. Analysis of variance
(ANOVA) was used to compare LC50s between the
three data sets. As all control deaths were below 10 %,
no mortality data were corrected.
Repellence tests
Repellence tests were conducted using standard choice-
chamber bioassays. Initially, two C8910 repellent formu-
lations developed by Stratacor Inc. (Richmond, CA) were
supplied. Each of these consisted of 15 % C8910 as the
active ingredient, suspended in a mineral oil carrier and
scented with original green leafy (formulation 1) and
modified green leafy (formulation 2) fragrances. A
C8910 fatty acid blend produced by Emery Oleochem-
icals (Cincinnati, OH) was suspended in mineral oil tocreate a third formulation, also comprising 15 % C8910.
This formulation was used for the repellence tests on
the ZamF strain.
In order to avoid residual repellents affecting subse-
quent bioassays, disposable cloths were treated with
5 ml of each formulation and partially wrapped around
the treatment forearm of each investigator. A cloth
treated with 5 ml DC345 silicon oil was wrapped around
each investigator’s alternate arm as a control. Positive
control tests on each colony/wild-caught sample were
conducted using a commercial product containing the
insect repellent DEET (N, N-diethyl-meta-toluamide-
19.5 %) as its active ingredient. The DEET product was
applied to the cloth of the treatment arm of each investi-
gator as described above. Three investigators participated
in the assays for C8910 formulations 1 and 2. Owing to
limited wild-caught material, only two investigators partic-
ipated in the assays for C8910 formulation 3.
Forty to fifty non blood-fed adult females per strain/
sample per replicate were starved of sugar solution for
12 h and then gently inserted into the choice-chamber.
They were left to acclimatize for 20 min in the dark in
climate-controlled conditions of 25 ± 2 °C and 75 %
humidity. The investigator concerned then placed the
treatment and control arms at either end of the choice-
chamber, so that each arm was 2 cm from the gauze-
covered end of the chamber. The number of mosquitoes
landing and attempting to blood-feed (hereafter referred
to as the number of landings) on either arm was re-
corded at 3 min intervals for a period of 15 min. During
counts, a red light was used to illuminate the chamber
so as to minimize disturbance. The repellence of each
formulation was assessed for each colony/sample through
three replicates per investigator.
Variation in the total number of landings on the con-
trol versus treatment arms at each time interval was
tested for significance using paired t-tests. These ana-




The dose-mortality response curves for each sample are
shown in Fig. 1. There was no statistically significant
difference in response between the three strains (one-
way ANOVA: F = 0.19, p = 0.83). In general, mortality
increased with increasing C8910 concentration for all
samples. However, this trend was least obvious in the
wild-caught ZamF sample, especially at the lower doses
(50-250 μg/ml a.i). A Tukey HSD post-hoc test of the
ZamF 50-250 μg/ml a.i dose range shows that the sig-
nificant trend (F = 3.4, p = 0.04) indicated by one-way
ANOVA does not reflect a significant difference in
mean mortalities.
Fig. 1 Mean percentage mortality of Anopheles funestus strains 24 h post-exposure to C8910. FANG (insecticide susceptible) and FUMOZ-R
(pyrethroid resistant) colonies as well as ZamF (wild caught) samples were exposed to C8910-treated bottles in accordance with the CDC bottle
bioassay protocol. C8910 exposure lasted 2 h, after which, the mosquitoes were removed and placed in non-treated holding containers. Mortality
was recorded 24 h after the initial exposure began. Three replicates were completed per dose per strain. Only one replicate of ZamF was
achieved at 350 μl/ml a.i bottle
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ities (LC50s) in each sample are shown in Fig. 2.
Although FUMOZ-R (254.39 ± 26.4 μg/ml a.i.) showed
the highest mean LC50 followed by FANG (241.25 ±
39.4 μg/ml a.i.) and ZamF (202.80 ± 56.3 μg/ml a.i.),
there was no significant variation in mean LC50 between
samples (one-way ANOVA: F = 0.4, p = 0.69).
Repellence tests
C8910 formulation 1 induced marked variation in mean
landing responses between investigators (Table 1). For
the FANG strain, significantly fewer landings were re-
corded on the control arm than the treatment arm of in-
vestigator 1. The reverse was true for investigator 2 for
whom significantly fewer landings were recorded on the
treatment arm than the control arm, while there was no
significant difference in the mean numbers of landings
on each arm of investigator 3. For the FUMOZ-R strain,
no significant difference in the mean numbers of
landings on each arm for any of the investigators was
recorded.
C8910 formulation 2 also induced marked variation in
mean landing responses between investigators (Table 2).
For the FANG strain, significantly fewer landings were
recorded on the control arm than the treatment arm of
investigator 1. The reverse was true for investigator 2 forwhom significantly fewer landings were recorded on the
treatment arm than the control arm, while there was no
significant difference in the mean numbers of landings
on each arm of investigator 3. For the FUMOZ-R strain,
significantly fewer landings were recorded on the treat-
ment arm than the control arm of investigator 2 only.
There were no significant differences in the mean num-
bers of landings on each arm of investigators 1 and 3.
For the ZamF sample, there were no significant differ-
ences in the mean numbers of landings on each arm of
both investigators using C8910 formulation 3 (Table 3).
Repellence tests using DEET showed zero landings on
the treatment arms of all investigators whereas multiple
landings were recorded on the respective control arm of
each investigator (Table 4).
Discussion
In general, C8910 proved equally toxic to adult females
of the pyrethroid resistant (FUMOZ-R) and insecticide
susceptible (FANG) An. funestus laboratory strains, as
well as to adult females of the wild-caught (ZamF) An.
funestus sample. It should be noted, however, that the
responses recorded for ZamF were more variable than
those recorded for the laboratory strains. This likely re-
flects greater genetic heterogeneity in the wild-caught
sample compared to the laboratory strains which are
Fig. 2 Mean lethal concentrations inducing 50 % mortality (LC50s) in Anopheles funestus strains 24 h post-exposure to C8910. Following C8910
exposure as per the CDC bottle bioassay protocol, LC50s were determined for each colony/wild-caught sample using regression lines of
log-transformed mortality data. Analysis of variance (ANOVA) was used to compare LC50s between the three data sets
Samuel et al. Parasites & Vectors  (2015) 8:321 Page 5 of 7expected to show reduced genetic variation, and thereby
reduced heterogeneity in response to insecticide in-
toxication, owing to laboratory colonisation and the ef-
fects of bottle-necking. The LD50 values recorded here
for An. funestus are reasonably comparable to thoseTable 1 Mean number of mosquito landings per arm recorded
during C8910 formulation 1 repellence assays
Mean ± SE p
Control Treatment
FANG
Investigator 1 10.4 ± 1.2 15.0 ± 1.1 0.01a
Investigator 2 17.4 ± 1.3 8.6 ± 1.4 0.03a
Investigator 3 9.0 ± 2.1 11.6 ± 1.5 0.44
All Investigators 12.3 ± 1.3 11.7 ± 1.0 0.80
FUMOZ-R
Investigator 1 2.0 ± 0.9 3.2 ± 1.0 0.54
Investigator 2 4.6 ± 0.8 6.2 ± 1.5 0.47
Investigator 3 3.0 ± 0.3 1.0 ± 0.6 0.08
All Investigators 3.2 ± 0.5 3.5 ± 0.81 0.79
Standard choice-chamber bioassays were performed on three investigators
using the laboratory-reared Anopheles funestus FANG (insecticide-susceptible)
and FUMOZ-R (pyrethroid-resistant) strains. Each arm of an investigator acted
as a control and treatment respectively. Results (p) of paired t-tests comparing
control vs treatment arms are given
aindicates significant difference at 95 % confidencerecorded for other anophelines including An. gambiae
(91.76 ug a.i./bottle), An. dirus (132.59 ug a.i./bottle),
An. farauti (118.17 ug a.i./bottle), An. freeborni (119.87
ug a.i./bottle), An. minimus (55.44 ug a.i./bottle) and
An. stephensi (112.58 ug a.i./bottle) [23], allowing forTable 2 Mean number of mosquito landings per arm recorded
during C8910 formulation 2 repellence assays
Mean ± SE p
Control Treatment
FANG
Investigator 1 2.4 ± 0.8 6.6 ± 0.9 0.02a
Investigator 2 8.6 ± 1.0 6.0 ± 0.6 0.03a
Investigator 3 8.6 ± 0.9 7.2 ± 1.2 0.42
All Investigators 6.5 ± 0.92 6.7 ± 0.62 0.85
FUMOZ-R
Investigator 1 3.4 ± 1.0 4.0 ± 1.0 0.75
Investigator 2 6.4 ± 1.3 1.2 ± 0.5 0.03a
Investigator 3 2.4 ± 0.5 3.0 ± 0.5 0.21
All Investigators 4.1 ± 0.7 2.7 ± 0.5 0.22
Standard choice-chamber bioassays were performed on three investigators
using the laboratory-reared Anopheles funestus FANG (insecticide-susceptible)
and FUMOZ-R (pyrethroid-resistant) strains. Each arm of an investigator acted
as a control and treatment respectively. Results (p) of paired t-tests comparing
control vs treatment arms are given
aindicates significant difference at 95 % confidence
Table 3 Mean number of mosquito landings per arm recorded
during C8910 formulation 3 repellence assays
Mean ± SE p
Control Treatment
ZamF
Investigator 1 3.6 ± 0.3 4.2 ± 0.4 0.21
Investigator 2 5.2 ± 0.7 6.6 ± 1.3 0.43
All investigators 4.4 ± 0.4 5.4 ± 0.8 0.24
Standard choice-chamber bioassays were performed on two investigators
using the wild-caught Anopheles funestus ZamF samples. Each arm of an
investigator acted as a control and treatment respectively. Results (p) of
paired t-tests comparing control vs treatment arms are given
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(30 min for An. gambiae, An. dirus, An. farauti, An.
freeborni, An. minimus and An. stephensi vs two hours
for An. funestus). Nevertheless, these data affirm the
toxicity range of C8910 against Anopheles mosquitoes
in general.
Based on CDC bottle bioassays similar to those used in
the experiments described here, adult FUMOZ-R females
show a 76.1 fold decrease in susceptibility to pyrethroids
compared to FANG [27]. Pyrethroid resistance in
FUMOZ-R is primarily mediated by the detoxifying cap-
abilities of at least two monooxygenase P450s [8, 28–30]
and the resistance phenotype is further enhanced by thick-
ened cuticles [31]. The population from which the ZamF
sample was derived also carries high levels of pyrethroid
resistance [25]. Although the resistance mechanisms in
this population have not been fully characterised as yet,
preliminary data derived from synergist bioassays show
that monooxygenases play a fundamentally important
role. Collectively, the C8910 mortality data presented
here suggest that monooxygenase-mediated pyrethroid
resistance in An. funestus offers no protection against
the toxic effects of C8910, and that this mixture of
compounds therefore shows potential as an adulticide
and as a “resistance breaker” for malaria vector control
directed against An. funestus.Table 4 Mean number of mosquito landings per arm recorded
during DEET repellence assays
Mean ± SE p
Control Treatment
FANG
Investigator 2 5.0 ± 0.6 0 0.01a
FUMOZ-R
Investigator 1 4.0 ± 1.3 0 0.04a
Standard choice-chamber bioassays were performed on investigators using
the laboratory-reared Anopheles funestus FANG (insecticide-susceptible) and
FUMOZ-R (pyrethroid-resistant) strains. Each arm of an investigator acted as a
control and treatment respectively. Results (p) of paired t-tests comparing
control vs treatment arms are given
aindicates significant difference at 95 % confidenceNone of the C8910 formulations tested gave any
conclusive indication of repellence against An. funestus.
Although two of the formulations were scented (2 %
original green leafy and 2 % modified green leafy fra-
grances), it is unlikely that the scent confounded the
experiments because the unscented formulation gave
similarly ambiguous results. It is possible that the 15 %
formulations are too weak to induce repellence. These
tests also suggest an investigator effect [32, 33] because
only the data for investigator 2 indicated some repel-
lence. However, compared to the data obtained using
DEET, which showed complete repellence against An.
funestus regardless of investigator, none of the tests
using C8910 suggested a repellent effect. These data are
surprising considering the demonstrations of repellence
against other arthropods including Aedes and Culex mos-
quitoes [18–20, 22], and further investigations against An.
funestus and other malaria vector species are required.
The fatty acids comprising C8910 have been approved
by the U.S. FDA and are categorized as “Generally rec-
ognized as safe” [23]. They have low mammalian toxicity
and are unlikely to pose significant environmental con-
cerns. Further studies will be required to assess the re-
sidual activity of C8910 as an An. funestus adulticide. A
promising mechanism for prolonging residual activity is
micro-encapsulation, and various strategies are currently
underway to produce formulations with extended activ-
ity [23]. The potential and efficacy of C8910 as a larvi-
cide also requires investigation, and studies are currently
underway to establish these for An. funestus.Conclusions
It is concluded that C8910 is equally effective as an adulti-
cide against pyrethroid resistant and insecticide suscep-
tible An. funestus. However, it did not show any consistent
repellence against laboratory reared and wild-caught fe-
male samples of this species. Nevertheless, C8910 shows
potential as an adulticide that can be used for malaria vec-
tor control, particularly in those instances where insecti-
cide resistance management is required. However, future
deployment as a public health intervention, most likely
in conjunction with traditional insecticides in a mosaic
or rotational strategy, will depend of further toxicity
assessments followed by formulation, phased trial and
commercialisation processes.
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